Cargando…
Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy
The purpose of this study was to investigate the effects of SLC22A2 808G>T polymorphism and trough concentrations (C(0)) of bosutinib on serum creatinine in 28 patients taking bosutinib. At 1, 3, 6, 12, 24, and 36 months after administration, analysis of bosutinib C(0) and creatinine was performe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973796/ https://www.ncbi.nlm.nih.gov/pubmed/33737618 http://dx.doi.org/10.1038/s41598-021-85757-7 |